BRD2 and COVID-19: The hypothalamic–pituitary–testicular (HPT) axis may be suppressed by an acute severe inflammatory situation, such as in the case of COVID-19, which results in lower levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone.